BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wahsh EA, Hussein AK, Gomaa AA, Baraka MA, Al-Deen Abead M. Real Life Egyptian Experience of Daclatasvir Plus Sofosbuvir with Ribavirin in Naïve Difficult to Treat HCV Patients. Infect Disord Drug Targets 2020;20:43-8. [PMID: 30009715 DOI: 10.2174/1871526518666180716141806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ahmed M, Mansey AE, Wahsh EA, Gomaa AA, Rabea HM. Efficacy and Safety of Ombitasvir plus Paritaprevir, Ritonavir and Ribavirin in Non-cirrhotic Treatment-naïve and Treatment-experienced Egyptians with Chronic HCV Genotype-4 Infection. Curr Med Sci 2021;41:581-6. [PMID: 34047942 DOI: 10.1007/s11596-021-2363-9] [Reference Citation Analysis]
2 Elmowafy AY, Abbas MH, Denewar AA, Mashaly ME, Shiha G, El Wasif SM, Rostaing L, Bakr MA. The effect of anemia on the efficacy and safety of treating chronic hepatitis C infection with direct-acting antivirals in patients with chronic kidney disease. Int Urol Nephrol 2021;53:749-61. [PMID: 33111161 DOI: 10.1007/s11255-020-02656-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]